Adding cisplatin to split course radiotherapy increases progression-free survival compared to radiotherapy alone in people with inoperable squamous cell esophageal cancer - Commentary Journal Article
| Author: | Ilson, D. H. |
| Article Title: | Adding cisplatin to split course radiotherapy increases progression-free survival compared to radiotherapy alone in people with inoperable squamous cell esophageal cancer - Commentary |
| Keywords: | adult; cancer survival; controlled study; treatment outcome; aged; major clinical study; clinical trial; drug tolerability; squamous cell carcinoma; cisplatin; cancer growth; radiation dose; controlled clinical trial; nausea; randomized controlled trial; vomiting; drug effect; survival time; cancer center; multicenter study; inoperable cancer; esophagus cancer; mannitol; hematologic disease; human; article |
| Journal Title: | Evidence-Based Oncology |
| Volume: | 2 |
| Issue: | 4 |
| ISSN: | 1363-4054 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2001-12-01 |
| Start Page: | 221 |
| End Page: | 223 |
| Language: | English |
| DOI: | 10.1054/ebon.2001.0162 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 21 May 2015 -- Source: Scopus |
